These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2121173)

  • 21. Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats.
    Momiyama T; Ishihara K; Kimura K; Todo N; Fujita Y; Serikawa T; Sasa M
    Epilepsia; 1996 Apr; 37(4):328-31. PubMed ID: 8603636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early infantile epileptic encephalopathy: report of one case.
    Huang LT
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(6):448-50. PubMed ID: 9074283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of mortality in early infantile epileptic encephalopathy: A systematic review.
    Radaelli G; de Souza Santos F; Borelli WV; Pisani L; Nunes ML; Scorza FA; da Costa JC
    Epilepsy Behav; 2018 Aug; 85():32-36. PubMed ID: 29906699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of early infantile epileptic encephalopathy (EIEE) with anatomical cerebral asymmetry and myoclonus.
    Ogihara M; Kinoue K; Takamiya H; Nemoto S; Miyajima T; Hoshika A; Honda T; Takashima S; Genton P; Dravet C
    Brain Dev; 1993; 15(2):133-9. PubMed ID: 8214333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ohtahara syndrome with emphasis on recent genetic discovery.
    Pavone P; Spalice A; Polizzi A; Parisi P; Ruggieri M
    Brain Dev; 2012 Jun; 34(6):459-68. PubMed ID: 21967765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early infantile epileptic encephalopathy].
    Martínez Bermejo A; Roche C; López Martín V; Pascual Castroviejo I
    Rev Neurol; 1995; 23(120):297-300. PubMed ID: 7497179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.
    Callahan AM; Frye MA; Marangell LB; George MS; Ketter TA; L'Herrou T; Post RM
    Biol Psychiatry; 1997 Feb; 41(3):264-72. PubMed ID: 9024949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood.
    Yoshinari S; Hamano S; Tanaka M; Minamitani M
    Eur J Paediatr Neurol; 2006 May; 10(3):124-8. PubMed ID: 16757195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and CNS effects of oral and I.V. Thyrotropin-releasing hormone in depressed patients.
    Itil TM; Patterson CD; Polvan N; Bigelow A; Bergey B
    Dis Nerv Syst; 1975 Sep; 36(9):529-36. PubMed ID: 809253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy.
    Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N
    J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRH increases cerebrospinal fluid concentration of kynurenine.
    Takeuchi Y; Matsushita H; Kawano H; Sakai H; Yoshimoto K; Sawada T
    Neuroreport; 1999 Nov; 10(17):3601-3. PubMed ID: 10619651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early infantile epileptic encephalopathy and glycine encephalopathy].
    González de Dios J; Moya M; Pastore C; Izura V; Carratalà F
    Rev Neurol; 1997 Dec; 25(148):1916-8. PubMed ID: 9528030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical and electroencephalographic characteristics of early myoclonic encephalopathy].
    Liu CT; Yin F; Huang R; Li B
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):899-902. PubMed ID: 23324144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of DN-1417 (TRH analog) on schizophrenic patients].
    Mizuki Y; Takada Y; Tsujimaru H; Takii O; Nishijima H
    Seishin Shinkeigaku Zasshi; 1983; 85(11):808-12. PubMed ID: 6146149
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive value of sequential electroencephalogram (EEG) in neonates with seizures and its relation to neurological outcome.
    Khan RL; Nunes ML; Garcias da Silva LF; da Costa JC
    J Child Neurol; 2008 Feb; 23(2):144-50. PubMed ID: 18160554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational use of EEG in childhood epilepsy.
    Rana KS
    Indian J Pediatr; 2000 Jan; 67(1 Suppl):S22-31. PubMed ID: 11129891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liposteroid therapy in a case of early infantile epileptic encephalopathy with suppression burst].
    Yoshikawa H; Ikeda S; Watanabe T
    No To Hattatsu; 1998 Nov; 30(6):551-4. PubMed ID: 9844423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.